News
Scilex Holding Preliminary Q1 Net Sales For ZTlido Were $12M-$13M; Q1 Gross Sales For ZTlido Were $34M-$38M; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other Administrative Expenses
16 Apr 24
Biotech, Earnings, News, Guidance, General
Scilex Holding Launches Co-Pay Programs For ZTlido And ELYXYB For Commercially Insured Patients And Addition Of ELYXYB To Multi-State Medicaid Pharmaceutical Purchasing Group To Purchasing Pool
9 Apr 24
News
Scilex Holding To Seek Approval Fro mFDA For Modification Of Gloperba To Include
20 Mar 24
News, FDA
Scilex Holding Company Sets Launch Price Of $595 Per 150ml Bottle Of Gloperba, Its Liquid Oral Version Of The Anti-Gout Medicine Colchicine Indicated For The Prophylaxis Of Painful Gout Flares In Adults; Expected Plans To Launch In The First Half Of 2024
5 Mar 24
Biotech, News, General
Reported Earlier, Scilex Announces Move To Extend Lockup Period For Sorrento-Distributed Dividend Shares Until September 2024
4 Mar 24
News
Crude Oil Rises Over 2%; Fisker Shares Plummet
1 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Global, Intraday Update, Markets, Trading Ideas
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
1 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Friday's Intraday Session
1 Mar 24
Movers
Nasdaq Surges 100 Points; ISM Manufacturing PMI Falls In February
1 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Global, Intraday Update, Markets, Trading Ideas
US Stocks Mixed; Dell Posts Upbeat Results
1 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Global, Intraday Update, Markets, Trading Ideas
Why NetApp Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
1 Mar 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Friday's Pre-Market Session
1 Mar 24
Movers
Hewlett Packard Enterprise Posts Mixed Q1 Results, Joins Fisker, Plug Power And Other Big Stocks Moving Lower In Friday's Pre-Market Session
1 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Scilex Holding Reveals $10M Bought Deal Offering
29 Feb 24
News, Offerings
Scilex Holding Company To Stock GLOPERBA In National Pharmacy Chain Stores
28 Feb 24
Biotech, News, General
Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics And Scilex Pharmaceuticals
27 Feb 24
Biotech, News, Health Care, Legal, General
Scilex Holding Announces ZTlido Milestones
26 Feb 24
Biotech, News, General
Scilex Holding Company Announces Publication In Anesthesiology Journal Of Results From An Investigator-Initiated Research Study Using ZTlido For The Treatment Of Chronic Neck Pain
20 Feb 24
Biotech, News, General
Press releases
Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross and Net Sales for ZTlido® for the First Quarter 2024; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other Administrative Expenses
16 Apr 24
Press Releases
Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured Patients
21 Mar 24
Health Care, Press Releases, General
Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is Needed
20 Mar 24
Press Releases
Scilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc.
15 Mar 24
Press Releases, General
Scilex Holding Company's Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of Such Release and Settlement
15 Mar 24
News, Legal, Press Releases
Scilex Holding Company Announces Closing of $10 Million Bought Deal Offering
5 Mar 24
News, Financing, Press Releases
Scilex Holding Company Sets Launch Price of $595 per 150ml bottle of Gloperba®, its First and Only Liquid Oral Version of the Anti-Gout Medicine Colchicine Indicated for the Prophylaxis of Painful Gout Flares in Adults; Expected Plans to Launch in the First Half of 2024
5 Mar 24
Press Releases, General
Scilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend from March 31, 2024 to September 30, 2024
2 Mar 24
News, Legal, Markets, Press Releases
Scilex Holding Company Announces $10 Million Bought Deal Offering
29 Feb 24
Press Releases
Scilex Holding Company's Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement Agreement
26 Feb 24
News, Legal, Press Releases